Jia Jie Biomedical Co., Ltd. (4109.TWO)
TWD 21.85
(0.0%)
TWD 21.85
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 332.75 Million | 317.71 Million | 242.48 Million | 270.29 Million | 343.06 Million |
| Cost of Revenue | 215.12 Million | 201.2 Million | 158.71 Million | 228.57 Million | 255.09 Million |
| Gross Profit | 117.63 Million | 116.5 Million | 83.77 Million | 41.71 Million | 87.96 Million |
| Operating Expenses | 183.83 Million | 130.89 Million | 84.99 Million | 90.03 Million | 108.66 Million |
| Selling, General and Administrative Expenses | 174.51 Million | 121.96 Million | 81.38 Million | 89.86 Million | 106.74 Million |
| Research and Development Expenses | 9.32 Million | 8.93 Million | 3.6 Million | 165 Thousand | 1.91 Million |
| Other Expenses | - | 7.91 Million | 5.8 Million | 7.28 Million | - |
| Cost and Expenses | 398.95 Million | 332.1 Million | 243.7 Million | 318.61 Million | 363.76 Million |
| Operating Income | -66.2 Million | -5.27 Million | 5.05 Million | -40.92 Million | -20.69 Million |
| Interest Expense | 348 Thousand | 113 Thousand | 61 Thousand | 713 Thousand | 2.89 Million |
| Income Tax Expense | -475 Thousand | 1.76 Million | 191 Thousand | -8.95 Million | -1.04 Million |
| Earnings before Tax | 146.54 Million | -4.68 Million | 5.29 Million | -41.65 Million | -25.46 Million |
| Net Income | 144.14 Million | -5.47 Million | 5.34 Million | -31.92 Million | -24.48 Million |
| Earnings Per Share Basic | 1.62 | -0.06 | 0.06 | -0.46 | -0.36 |
| Earnings Per Share Diluted | 1.62 | -0.06 | 0.06 | -0.46 | -0.36 |
| Weighted Average Shares Outstanding | 88.93 Million | 88.93 Million | 88.93 Million | 69.42 Million | 68.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 89.19 Million | 88.93 Million | 88.93 Million | 69.42 Million | 68.93 Million |
| Gross Margin | 0.35 | 0.37 | 0.35 | 0.15 | 0.26 |
| EBIT Margin | 0.49 | 0.04 | 0.08 | -0.09 | -0.01 |
| Profit Margin | 0.43 | -0.02 | 0.02 | -0.12 | -0.07 |
| EBITDA | 161.78 Million | 12.11 Million | 18.57 Million | -25.5 Million | -4.33 Million |
| Earnings Before Tax Margin | -0.20 | -0.02 | 0.02 | -0.15 | -0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 151.2 Million | 160.01 Million | 84.55 Million | 332.75 Million | 82.88 Million | 87.06 Million |
| Cost of Revenue | 102.45 Million | 109.02 Million | 64.33 Million | 215.12 Million | 48.3 Million | 56.56 Million |
| Gross Profit | 48.75 Million | 50.99 Million | 20.22 Million | 117.63 Million | 34.58 Million | 30.5 Million |
| Operating Expenses | 41.74 Million | 34.9 Million | 46.13 Million | 184.11 Million | 35.51 Million | 46.56 Million |
| Selling, General and Administrative Expenses | 39.81 Million | 32.91 Million | 43.59 Million | - | 32.92 Million | 44.53 Million |
| Research and Development Expenses | 1.92 Million | 1.99 Million | 2.53 Million | - | 2.59 Million | 2.02 Million |
| Other Expenses | 211.36 Million | 2.05 Million | 183.25 Million | 210.96 Million | 22.29 Million | 4.11 Million |
| Cost and Expenses | 144.19 Million | 143.92 Million | 110.46 Million | 399.24 Million | 83.82 Million | 103.12 Million |
| Operating Income | 219.34 Million | 18.23 Million | 158.37 Million | 146.61 Million | 21.47 Million | -11.3 Million |
| Interest Expense | 38 Thousand | 548 Thousand | 295 Thousand | 348 Thousand | 26 Thousand | 13 Thousand |
| Income Tax Expense | 3.55 Million | 4.14 Million | -3.3 Million | -475 Thousand | 1.52 Million | 587 Thousand |
| Earnings before Tax | 219.19 Million | 17.97 Million | 158.16 Million | 146.54 Million | 21.45 Million | -11.23 Million |
| Net Income | 214.69 Million | 13.31 Million | 160.73 Million | 144.14 Million | 19.02 Million | -12.83 Million |
| Earnings Per Share Basic | 2.17 | 0.14 | 1.79 | - | 0.21 | -0.14 |
| Earnings Per Share Diluted | 2.17 | 0.14 | 1.79 | - | 0.21 | -0.14 |
| Weighted Average Shares Outstanding | 98.93 Million | 95.07 Million | 89.77 Million | 88.93 Million | 90.61 Million | 91.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 98.93 Million | 95.07 Million | 89.9 Million | 89.19 Million | 90.61 Million | 91.64 Million |
| Gross Margin | 0.32 | 0.32 | 0.24 | 0.35 | 0.42 | 0.35 |
| EBIT Margin | 1.48 | 0.14 | 1.92 | - | 0.31 | -0.09 |
| Profit Margin | 1.42 | 0.08 | 1.90 | 0.43 | 0.23 | -0.15 |
| EBITDA | 223.36 Million | 22.28 Million | 161.99 Million | - | 25.48 Million | -7.82 Million |
| Earnings Before Tax Margin | 1.45 | 0.11 | 1.87 | 0.44 | 0.26 | -0.13 |
3223
RAYMOND
KHAITANLTD
CHMI-PB
TMD
3114